Jiang L, Xu J, Jiang C, Jia Y, et al. BHLHE22, targeted by deubiquitinating enzyme OTUD3, exerts an antitumor role in triple-negative breast cancer progression via transcriptionally inhibiting CDT1. Breast Cancer Res 2026 Jan 2. doi: 10.1186/s13058-025-02198.
PMID: 41484895